This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When radiologists interpretations are indeterminate, a commercially available deep learning algorithm could find clinically significant prostate cancer with improved specificity while maintaining sensitivity, suggested research published March 11 in Radiology. A majority (179) of participants underwent multiparametric MRI, the authors noted.
And 2023 is no exception. The technology figured prominently in five Minnies categories, including Hottest Clinical Procedure. Workforce shortages were deemed by our Expert Panel to be the biggest threat in 2023. Menias’ clinical focus has been geared to patient-centered care, and she’s absolutely unwavering.
Welcome to the first installment of this year’s Road to RSNA preview of the RSNA 2023 meeting. AI’s capability and potential to enhance the practice of radiology will take center stage at RSNA 2023. For more information on those presentations and other abstracts, check out the RSNA 2023 meeting program. 9:40 a.m. | 9:40 a.m. |
Ultrasound's utility will be on full display at this year's RSNA annual meeting, showing its merit in a wide variety of clinical applications. Research to be presented at the annual meeting in Chicago will explore the modality's clinical applications in musculoskeletal, pediatric, abdominal, and women's imaging among other areas.
Here, we’ve highlighted just a small sample of digital x-ray presentations scheduled for RSNA 2023. You can also view the complete 2022 scientific and educational program on the RSNA 2023 website. Generative AI enables patient-specific THA surgical templating Sunday, November 26 | 1:00 p.m.-1:10 1:10 p.m. | 2:00 p.m. |
It was no surprise that AI created a buzz at RSNA 2023, but what were the meaningful take-home messages? A few new point solutions (clinical decision support CDS or diagnostic) from established vendors but no game changers. Hugh Harvey, MD, managing director of Hardian Health in the U.K., has a list of nine to consider.
While ChatGPT landed two spots in the top 10 most popular articles in 2023, what grabbed the attention of the radiology community the most varied along five other theme lines. We’ve since learned that looking ahead into 2024, 72% of CT sites anticipate that their 2024 CT procedures will increase compared to 2023.
Despite evidence suggesting a link between depression and faster clinical progression in patients with Alzheimers disease, the biological mechanisms underlying this association are poorly understood, the authors explained. The study was published April 9 in the American Journal of Geriatric Psychiatry.
In this study, the researchers enrolled 10 participants with Alzheimers disease (mean age, 72 years old) and five healthy participants between April and October 2023. They compared the DMI results to clinical FDG-PET data from patient records. A graphical abstract of the study. Image courtesy of RSNA.
CHICAGO -- GE HealthCare (GEHC) brought new CT and MRI scanners and a range of AI software applications to McCormick Place for RSNA 2023. Interventional In image-guided surgery activities, GEHC showcased two new AI applications previously presented at ECR 2023. MRI GEHC unveiled Signa Champion, a 1.5-tesla,
Researchers led by Ronnie Sebro, MD, PhD, of the Mayo Clinic in Jacksonville, FL, found that patients experience a loss in bone mineral density (BMD) after transplant, which puts them at higher risk for osteoporosis and fractures.
At RSNA 2023, look for AI-driven systems that radiographers can use to help make patient positioning faster and more precise, and bring consistency to the process, all of which help improve image quality and reduce the need for retakes. In healthcare, it has the potential to improve diagnostic and treatment processes.
Commercial AI devices that lack adequate clinical validation may pose risks for patient care – and unfortunately, that’s true for almost half of the tools cleared so far by the U.S. Most notably, 226 of 521 (43%) lacked published clinical validation data.
Surveying the landscape of interpretive AI in radiology, two researchers note a yawning gap between great expectations set in the recent past and actual clinical implementations as of spring 2023.
An automated segmentation tool called TotalSegmentator CT was released in August 2023, and since then there has been demand for a similar tool that can be applied across all MRI sequences and anatomic structures, the group explained. To this end, D'Antonoli and colleagues built TotalSegmentator MRI, which they based on nnU-Net.
Radiation therapy clinic software provider RaySearch Laboratories highlighted a net sales increase of 21% in its 2023 annual report, posting 1.02 in 2023, up from 5.1% in 2023, up from 5.1% billion Swedish krona ($93.2 million U.S.). The Stockholm, Sweden-based company also reported an operating loss/profit of 114.9
Researchers from donanemab developer Eli Lilly presented a follow-up analysis of data from the TRAILBLAZER-ALZ 2 clinical trial at the Clinical Trials on Alzheimer’s Disease (CTAD) 2023 conference in Boston. Food and Drug Administration, with a decision expected by the end of 2023. The full report is available here.
million), comparable to the same quarter in 2023. Median's revenue is achieved entirely by the iCRO1 business, which delivers services to the global biopharmaceutical industry for image management in oncology clinical trials. Additionally, the company reported that for the full 2023 fiscal year, net loss reached 23 million euros ($24.7
Continuing to expand its ultrasound AI capabilities, GE HealthCare has signed an agreement to acquire Wales-based Intelligent Ultrasound Group's clinical AI software business for total consideration of approximately $51 million. Intelligent Ultrasound Chief Operating Officer Nick Sleep will also come over to GE HealthCare.
ClearPoint Neuro posted increases in revenue in its fourth quarter and full-year 2023, citing an uptick in sales related to customer-sponsored preclinical and clinical trials. In addition, the company posted a total revenue of $24 million for full-year 2023, up from $20.6 million for year-end 2023, up from $9.1
Read more on AuntMinnie.com Related Reading: Video from SIIM 2023: There's more to generative AI than ChatGPT SIIM: CT techs can facilitate clinically meaningful AI Video from SIIM 2023: SIIM Chair Tessa Cook recaps Day 1 SIIM: Imaging AI developers need meaningful training data SIIM: AI can aid interpretation of TTE exams
in 2023 to 16% in 2024 -- a shift likely due to a change in methodology, according to researchers. Its strengths include detailed clinical data collection, standardized reporting through Lung-RADS, and quality metrics beyond screening completion rates.
Medicare population, a study presented at RSNA 2023 found. Aditya Khurana, MD, from the Mayo Clinic in Rochester, MN, discussed the results he presented with AuntMinnie.com, as well as how they point to quality and workforce challenges.
Clinical Scenario: A 6-year-old boy presents to the Peds ED with an injury to their left 2nd digit. The NINJA trial , performed in 2023, randomized ~ 450 children with nail bed injuries to primary repair with nail/substitute replacement versus no replacement. The finger was caught in a car door, injuring the nail and nail bed.
As of January 2023, hybrid iterative reconstruction (HIR) -- a blend of FBP and MBIR -- was the state-of-the-art image reconstruction technique, according to Lennart Koetzier; Martin Willemink, PhD; and colleagues, who wrote about the technical principles and clinical prospects for the RSNA journal Radiology. Tim Leiner, MD, PhD.
In the context of medical devices, an in silico clinical trial (ISCT) is a computational study in which a medical intervention is evaluated using a cohort of computational models of patients, wrote lead author Pras Pathmanathan, PhD, a senior FDA research scientist, and colleagues. Read the full paper here.
The finding is from a study that validated a fast protocol in 121 clinical patients, with seven independent readers giving the algorithm high scores for reducing image noise and improving image sharpness, noted lead author Jan Vosshenrich, MD, of New York University in New York City, and colleagues.
RadNet executives will spend the next 18 months learning what does and doesn't work for operating small in-store retail breast cancer screening clinics in three areas of the U.S. In early December 2023, the first of RadNet's three pilot MammogramNow clinics opened in a Walmart Supercenter in Milford, DE. Then, in 2022, the U.S.
Most Influential Radiology Researcher Erik Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik Middlebrooks, MD. One of this year's nominations for Most Influential Radiology Researcher is Erik Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL. Elliot Fishman, MD.
In 2023, nonhospital sites faced more competition compared with hospital-based facilities for oncology-related diagnostic imaging scans, according to IMV’s recently published 2023 Oncology in Diagnostic Imaging Market Outlook Report. Davin Korstjens. out of 5 rating (with 5 indicating very high importance) compared with a 2.7
Congratulations to our 2023 graduates and award recipients. Department faculty, alumni and senior department administrators attended the celebration, which included a number of award presentations for outstanding achievements in teaching, mentoring, clinical care, research and service.
Before integrating large language models (LLMs) into clinical or educational settings, a thorough understanding of their accuracy, consistency, and stability over time is paramount,” the group wrote. Since their introduction, LLMs like GPT-4, GPT-3.5, The researchers queried GPT-4, GPT-3.5,
Our study highlights the pressing need for more robust and continuous large language model monitoring systems before clinical deployment,” Li and colleagues wrote. It selected 287 cases published between 1998 and 2023. The team investigated the respective diagnostic accuracy of ChatGPT-3.5 Finally, diagnostic accuracy increased by 17.3%
performs well on the image-independent American College of Radiology Diagnostic In-Training Exam (ACR DXIT) practice questions, a study presented November 29 at the RSNA 2023 annual meeting found. Previous studies have examined these models and their clinical utility in clinical- and patient-facing settings.
The ACR remains committed to achieving regulatory, legislative and clinical environments that enable the highest quality patient care. Last year, the society reported fiscal results (end-June 30, 2023) that included revenue of $130 million and expenses of $137.5 The College will have no further comment on this personnel matter."
Read more on AuntMinnie.com Related Reading: ViewRay touts results of MIRAGE trial ViewRay highlights clinical results at ASTRO SUNY Upstate installs ViewRay radiation therapy system ViewRay signs MD Anderson Cancer Center ViewRay's radiation therapy system can be sold in China
Lumicell highlighted clinical results presented at the recent Society of Surgical Oncology (SSO) in Atlanta, GA, that it says demonstrate the benefits of its Lumisight optical imaging agent for breast cancer.
As we approach the end of this remarkable year, we want to take a moment to reflect on the incredible journey we’ve in 2023. In August, 2023, CurveBeam AI was listed on the Australian Securities Exchange (ASX) under ticker symbol CVB. The post Countdown the Top 5 of 2023 with CurveBeam AI appeared first on CurveBeam AI.
christine.book Tue, 10/03/2023 - 11:37 October 3, 2023 — Medical device company GT Medical Technologies, Inc. 2 poster presentation at the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023 , being held this week in San Diego, CA.
“We constructed a newly effective model for the prediction of ALNM … which provides an alternative option for breast cancer patients in the early stage and demonstrates its potential in practical clinical applications,” Dong and co-authors wrote. The group used clinicopathological data and ultrasound features to create the nomogram.
Building on these findings, the hospital fully integrated AI in mid-2023 and became the first in the world to implement AI as an independent reader, fully replacing one radiologist. Previously, the waiting time for a clinical mammogram was five to six weeks. to 2.5%, minimizing unnecessary follow-ups for patients.
Whilst supply chain issues are under control in 2023, as vendors become more flexible with their supply chains and have adapted, further price rises are expected, albeit to a lesser extent than in 2022. This is becoming more prevalent in 2023, given the worsening economic climate. Continue to purchase as usual and pay higher prices.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content